Jianxiang Wang - Concepedia

Author

Jianxiang Wang

Institute of Hematology & Blood Diseases Hospital ORCID

Also Known As

J Wang, J X Wang, JIANXIANG WANG, Jian-Xiang Wang, Jian-xiang Wang, JianXiang Wang, Jianxiang Wang, Jian‐Xiang Wang, Lalit Kumar, Min Wang

834

Publications

18K

Citations

H-Index

125

Concepts

All Affiliations

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College The University of Texas MD Anderson Cancer Center Peking University National Heart Lung and Blood Institute

About

Jianxiang Wang is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	87	4.8K
2	Health Sciences	17	19	1.1K
3	Natural Sciences	4	4	782
4	Engineering	2	2	38
5	Public Health	2	2	81

Jianxiang Wang

193

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum, Blood	2022	2.7K
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, New England Journal of Medicine	2020	2.6K
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes, Blood	2011	601
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex Jianxiang Wang, Taizo Hoshino, Robert L. Redner, Proceedings of the National Academy of Sciences Mixed-phenotype Acute LeukemiaGeneticsImmunologyAml1/eto FusionEpigenetics	1998	518
Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia Pau Montesinos, Christian Récher, Susana Vives, New England Journal of Medicine	2022	448
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial Harry P. Erba, Pau Montesinos, Hee‐Je Kim, The Lancet Hematological MalignancyMedicineHematologyClinical TrialsMyeloid Neoplasia	2023	319
Identification of functional cooperative mutations of SETD2 in human acute leukemia Xiaofan Zhu, Fuhong He, Huimin Zeng, Nature Genetics Hematological MalignancyChromatinSomatic VariantMixed-phenotype Acute LeukemiaGenetics	2014	246
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Jianxiang Wang, Yogen Saunthararajah, Robert L. Redner, PubMed Histone ModificationsChimeric Fusion ProductEpigenetic ChangeEto-mediated RepressionEpigenetics	1999	197
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Likun Li, Guang Yang, Shin Ebara, PubMed Prostate Cancer CellsMetastatic ActivitiesCancer BiologyTumor BiologyVector Control Clones	2001	191
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells Yasutomo Nasu, Terry L. Timme, Guang Yang, Nature Medicine UrologyMedicineHormonal ReceptorProstatic DiseaseEndocrinology	1998	185

Page 1